agilon health, inc.
| Company Name | agilon health, inc. |
| Stock Symbol | AGL |
On August 4, 2025, agilon disclosed that its President, CEO, and Director of the Board was departing the Company, and that his departure “was a termination without ‘cause’ under [his] employment agreement.” That same day, agilon released its second quarter 2025 financial results, missing estimates and further announcing that it was suspending its 2025 guidance due to the leadership change “as well as continued execution of ongoing initiatives and market uncertainty which may impact future results.”
On this news, agilon’s stock price fell $0.93, or 51.5%, to close at $0.88 per share on August 5, 2025, thereby injuring investors.
Submit Your Information
If you suffered a loss on your agilon health, inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.